CA Patent

CA2086233C — In vitro leaf petiole multiplication of pelargoniums

Assigned to Oglevee Ltd · Expires 1995-10-17 · 31y expired

What this patent protects

A process for propagating Pelargonium x domesticum varieties by tissue culture propagation of petiole sections taken from a mother plant. In addition to tissue culture propagation steps and growth media constituents which are known in the art, an es-sential step of the preferred …

USPTO Abstract

A process for propagating Pelargonium x domesticum varieties by tissue culture propagation of petiole sections taken from a mother plant. In addition to tissue culture propagation steps and growth media constituents which are known in the art, an es-sential step of the preferred embodiment of the invention includes the conducting of callus formation by initial culturing of the petiole section in the dark. In all embodiments of the invention, however, it is believed that the effectiveness of the present pro-cess is attributable at least in part to the presence in the culture medium of a growth regulator selected from the group consisting of amino or benzyl-glucosides and amino- or benzyl-glycosides or any other composition chemically equivalent to the exemplary regulator benzylamino riboside.

Drugs covered by this patent

Patent Metadata

Patent number
CA2086233C
Jurisdiction
CA
Classification
Expires
1995-10-17
Drug substance claim
No
Drug product claim
No
Assignee
Oglevee Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.